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Background:  Periprosthetic  joint  infection  often  raises  diagnostic  challenges,  as the  published  criteria
are  heterogeneous.  New  markers  for predicting  periprosthetic  infection  have  been  evaluated.  Here,  we
assessed  one  of  these  markers,  C-reactive  protein  (CRP),  in joint  ﬂuid.
Hypothesis:  We  hypothesised  that  intra-articular  CRP  levels  would  perform  better  than  serum  CRP  con-
centrations  in  diagnosing  knee  prosthesis  infection.
Patients and  methods:  We  prospectively  included  30 patients  including  10 with native-knee  effusions,
11  with prosthetic-knee  aseptic  effusions,  and  11  with  prosthetic-knee  infection  deﬁned  using  2011
Musculoskeletal  Society  criteria.  Serum  CRP was  assayed  using  turbidimetry  or  nephelometry  and  intra-
articular  CRP  using  nephelometry.  Appropriate  statistical  tests  were  performed  to compare  the  three
groups;  P values  < 0.05  were  considered  signiﬁcant.
Results:  Serum  and  intra-articular  CRP  levels  were  5-  to  16-fold  higher  in  the  group  with periprosthetic
infection  than  in  the  other  two groups.  Although  the  areas under  the  ROC  curves  were  not  signiﬁcantly  dif-
ferent,  the likelihood  ratios  associated  with  the  selected  cut-offs  suggested  superiority  of intra-articular
CRP:  a value  > 2.78 mg/L  suggested  possible  infection  (100%  sensitivity  and  82%  speciﬁcity)  and  a  value
>  5.37  mg/L  probable  infection  (90%  sensitivity  and  91%  speciﬁcity).
Discussion:  Our ﬁndings  suggest  a possible  role  for intra-articular  CRP  assay  in  diagnosing  knee  prosthesis
infection  and perhaps  periprosthetic  infection  at any  site.
Level  of evidence:  Level  III, diagnostic  study,  development  of a diagnostic  criterion  in  consecutive  patients
nce  scomparatively  to  a refere
. Introduction
Periprosthetic joint infection places a huge medical and eco-
omic burden on public health [1,2]. This potentially severe
omplication occurs in about 1 to 4% of knee prostheses and 0.5
o 2% of hip prostheses [3–7]. The diagnosis rests on a set of clin-
cal, laboratory, histological, and microbiological criteria [8–10].
owever, published diagnostic criteria are heterogeneous [11].
icrobiological studies play a crucial role in diagnosing peripros-
hetic infection but cannot be used alone as they are negative in
 [11] to 23% [12] of conﬁrmed cases. In addition, the presence of potential contaminant (e.g., coagulase-negative Staphylococcus)
n a single specimen is not sufﬁcient to establish the diagnosis of
eriprosthetic infection. Parvizi et al. recently developed a set of
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diagnostic criteria that is now widely accepted [13]. Nevertheless,
these criteria are not perfect, and their absence does not completely
rule out periprosthetic infection.
The inadequate diagnostic performance of conventional criteria
has prompted a search for new markers capable of predict-
ing periprosthetic infection. Examples include leukocyte-esterase
activity, inﬂammatory cytokine levels, and growth factor levels
in intra-articular ﬂuid from prosthetic joints [14,15]. The most
promising marker to date may  be C-reactive protein (CRP) [16].
Here, our objective was to assess the diagnostic accuracy
of intra-articular CRP in knee prosthesis infection. Our working
hypothesis was that intra-articular CRP performed better than
serum CRP in diagnosing knee prosthesis infection.2. Patients and methods
Speciﬁc ethics committee approval was not required, as no spe-
ciﬁc interventions were required for the study.
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Table 1
Baseline patient characteristics.
Native knee
n = 10
Prosthesis, aseptic effusion
n = 11
Prosthesis, infection
n = 10
Age (years) 69.8 (52–87) 79.8 (67–89) 74.3 (55–88) NS
%  females 80 54.5 70 NS
Body  weight (kg) 85.6 (63–101) 79.9 (51–105) 93.9 (60–144)
(DM 1)
NS
Height (m)  1.65 (1.58–1.80)
(DM1)
1.66 (1.45–1.85)
(DM 1)
1.65 (1.55–1.83)
(DM 1)
NS
Body mass index (kg/m2) 31.78 (26.91–40.46) 29.66 (24.26–36.57)
(DM 1
34.76 (22.09–56.96) NS
T
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native-knee group (rho = 0.95; P < 0.001) but not in the prosthesis-
aseptic effusion group (rho = 0.61; P = 0.07) or prosthetic infection
group (rho = 0.67; P = 0.06).(DM 1)
he data are median (range). NS: non-signiﬁcant.
Between February and August 2012, we prospectively included
1 patients seen at the orthopaedic surgery and rheumatology
epartments of the Strasbourg university hospital, Strasbourg,
rance. Among them, 10 had an aseptic effusion in a native knee, 11
n aseptic effusion in a prosthetic knee, and 10 a knee prosthesis
nfection. Among patients with knee prostheses, aseptic effusion
nd infection were distinguished based on 2011 Musculoskeletal
nfection Society criteria [13].
We  collected the following baseline data: age, sex, body mass
ndex, risk factors for infection (diabetes, smoking, anti-thrombotic
herapy), and time since prosthesis implantation.
Joint ﬂuid was obtained by aspiration of the joint cavity during
ither an outpatient visit or a surgical procedure. Intra-operative
spiration was performed before opening the capsule, to avoid
ontamination with blood. In everyday practice, microbiological
tudies are obtained routinely and cytological studies as deemed
ecessary by the physician. Residual joint ﬂuid, in a volume of at
east 1 mL,  was placed in an SST gel tube and used to assay CRP.
lood was drawn at the same time for a serum CRP assay.
Biochemical assays were performed at the biochemistry labora-
ory of the biology technical platform of the Strasbourg university
ospital. Serum CRP was assayed using turbidimetry or nephelom-
try. Nephelometry provides accurate CRP quantiﬁcation when
he CRP level is below the threshold detectable by turbidimetry
ultrasensitive CRP, usCRP). Intra-articular CRP was  assayed by
ephelometry; the time and cost needed for this test were similar
o those of the serum usCRP assay. Results are reported in mg/L.
.1. Statistics
Serum and intra-articular CRP levels in the three groups were
ompared using the Kruskal-Wallis test. Pairwise comparisons
ere then performed using the Mann-Whitney test corrected
ccording to the Steel-Dwass-Critchlow-Fligner procedure.
Within-patient comparisons of serum and intra-articular CRP
evels were performed with the Wilcoxon test for paired data.
pearman’s test was used to assess correlations. This analysis was
onducted in the overall population and in each of the three groups.
To determine the best cut-offs for serum and intra-articular CRP
evels, we determined the area under the receiver-operating char-
cteristics curves (AUC-ROC). The AUC-ROC values for serum and
ntra-articular CRP were compared using the Delong test. The cut-
ffs associated with the optimal compromise between sensitivity
nd speciﬁcity were identiﬁed and their likelihood ratios (LRs) were
omputed.
Values of P < 0.05 were considered signiﬁcant.
. Results.1. Baseline patient characteristics
At baseline, the groups did not differ signiﬁcantly regarding age,
ody weight, height, body mass index, or risk factors for infection.) (DM 1)
In the native-knee group, two patients had conditions likely to
affect inﬂammation marker levels (inﬂammatory joint disease and
chronic viral hepatitis, respectively). Mean time since prosthesis
implantation was  10.6 years in the group with aseptic effusion and
3.8 years in the group with prosthesis infection. None of the patients
had had the knee prosthesis implanted within 1 month before col-
lection of the study samples (Table 1).
3.2. CRP values
Serum CRP levels differed signiﬁcantly across the three groups.
In the group with prosthetic infection, the serum CRP level was ﬁve
times higher than in the prosthesis-aseptic effusion group and 16
times higher than in the native-knee group (P < 0.05 and P < 0.001,
respectively; Fig. 1), (Table 2).
Intra-articular CRP levels also differed signiﬁcantly across the
three groups (P < 0.001). The value in the group with prosthetic
infection was  six times higher than in the prosthesis-aseptic effu-
sion group and 12 times higher than in the native-knee group
(P < 0.01, Fig. 2). Intra-articular CRP levels were not signiﬁcantly
different between the prosthesis-aseptic effusion group and the
native-knee group.
3.3. Pairwise comparisons of serum and intra-articular CRP levels
overall and in each group
We  found a strong correlation between serum and intra-
articular CRP levels in the overall population (rho = 0.90, P < 0.001,
Fig. 3). The two values correlated signiﬁcantly with each other in theFig. 1. Serum CRP in mg/L (mean ± SD). Group 1: native knee, n = 10; group 2,
knee prosthesis, aseptic effusion, n = 11; group 3, knee prosthesis infection, n = 10.
*P  < 0,05; ***P < 0.001.
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Table  2
C-reactive protein (CRP) levels.
Native knee
n = 10
Prosthesis, aseptic effusion
n = 11
Prosthesis, infection
n = 10
Serum CRP (mg/L) 4.53 (0.39–15.20) 4.69 (0.94–66.50) 52.00 (19.50–225.00) ***
Intra-articular CRP (mg/L) 1.25 (0.27–7.60) 0.69 (0.17–30.80) 13.95 (4.39–92.10) ***
The data are median (range). ***P < 0.001.
Fig. 2. Intra-articular CRP in mg/L (mean ± SD). Group 1: native knee, n = 10; group
2,  knee prosthesis, aseptic effusion, n = 11; group 3, knee prosthesis infection, n = 10.
**P  < 0.01; ***P < 0.001.
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Fig. 4. ROC curves for serum and intra-articular CRP levels. The curves were plotted
using the intra-articular CRP levels measured in the group with knee prosthesis and
aseptic effusion (n = 9) and the group with infected knee prosthesis (n = 10).
Table 4
Cut-offs for serum C-reactive protein (CRP) values.
Cut-off
(mg/L)
Sensitivity
(%)
95%CI Speciﬁcity
(%)
95%CI Likelihood
ratio (LR+)
>14.95 100 69.2–100 77.78 40.0–97.2 4.5Fig. 3. Correlation between serum and intra-articular CRP levels.
.4. Serum and intra-articular CRP cut-offs for diagnosing
eriprosthetic infection
The ROC curve analysis identiﬁed two intra-articular CRP cut-
ffs, with different intrinsic characteristics, for the diagnosis of
eriprosthetic infection (Fig. 4). The 2.78 mg/L cut-off was 100%
ensitive and the 5.37 mg/L cut-off was 90.91% speciﬁc (Table 3).
he positive likelihood ratios were 5.5 and 9.9 for these two  intra-
rticular CRP cut-offs compared to 4.5 and 4.09 for the two serums
RP cut-offs (Table 4), indicating better diagnostic performance of
ntra-articular CRP.
able 3
ut-offs for intra-articular C-reactive protein (CRP) values.
Cut-off
(mg/L)
Sensitivity
(%)
95%CI Speciﬁcity
(%)
95%CI Positive
likelihood
ratio
>2.780 100 69.2–100 81.82 48.2–97.7 5.5
>5.365 90 55.5–99.8 90.91 58.7–99.8 9.9
5%CI: 95% conﬁdence interval.>51.75 50 18.7–81.3 88.89 51.8–99.8 4.5
95%CI, 95% conﬁdence interval.
4. Discussion
In this study, intra-articular CRP performed better than serum
CRP in diagnosing knee prosthesis infection.
CRP is a protein released by the liver, in amounts that increase
during systemic inﬂammatory processes. Other cells may  be able to
produce CRP, for instance within atheroma plaques [17], but no evi-
dence of production by the synovial membrane has been reported.
Given that CRP activates the complement cascade, higher CRP levels
would be expected at the initial site of infection, i.e., within the joint
in the case of periprosthetic infection [18]. There is consequently a
rationale for using intra-articular CRP assay as a diagnostic tool for
periprosthetic infection.
CRP was initially evaluated in synovial ﬂuid samples from native
joints. Zamani et al. found a mean level of 12.72 mg/L in patients
with inﬂammatory arthritis and 2.36 mg/L in those with mechan-
ical joint effusions [19]. Parvizi et al. measured intra-articular
CRP levels in 59 patients with joint prostheses, including 25 with
periprosthetic infections, and found signiﬁcantly higher values in
the group with infection (22.49 mg/L versus 1.19 mg/L in the group
without infection) [6]. Our data conﬁrm the considerable CRP eleva-
tion in synovial ﬂuid from joints with periprosthetic infection and
the low CRP values in synovial ﬂuid from native joints or uninfected
prosthetic joints.
Parvizi et al. determined that 9.5 mg/L was the best cut-off for
diagnosing periprosthetic infection, with 85% sensitivity and 95%
speciﬁcity [20]. Our results suggest that two  cut-offs should be con-
sidered: intra-articular CRP levels greater than 5.37 mg/L indicate
probable infection and those greater than 2.78 mg/L possible infec-
tion. When the intra-articular CRP level is lower than 2.78 mg/L,
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eriprosthetic infection can be ruled out. Nevertheless, compar-
sons of diagnostic cut-offs should be viewed with circumspection,
s the assay methods vary across studies. Standardisation of the
echniques and cut-offs would be helpful.
Thus, the intra-articular CRP assay may  perform better for the
iagnosis of periprosthetic infection than the serum CRP assay. The
UC-ROC was better for intra-articular CRP, although the differ-
nce was not statistically signiﬁcant. Nevertheless, the likelihood
atios associated with the cut-offs identiﬁed in our study support
he superiority of intra-articular CRP.
Our study has several limitations. Among patients with knee
rosthesis, those with and without infection were separated using
he criteria developed by Parvizi et al. [13], which have well-known
imitations. Given these diagnostic difﬁculties and the absence of a
athognomonic criterion for periprosthetic infection, longer-term
ollow-up data on our patients are needed to look for delayed
ymptoms of previously latent chronic periprosthetic infection. Our
ample size was limited, and a larger sample might have produced
ifferent results; however, the differences were evaluated using
tatistical tests that provide valid information even for small sam-
les. CRP is found in blood and can therefore be reliably assayed in
oint ﬂuid only in the absence of bleeding. To minimise this poten-
ial source of bias, joint aspiration was performed before opening
he capsule in patients with knee prostheses.
Despite these limitations, our study identiﬁed two  intra-
rticular CRP cut-offs of potential usefulness for diagnosing
nee prosthesis infection. However, the AUC-ROC curves for
ntra-articular and serum CRP were not signiﬁcantly different. Nev-
rtheless, the likelihood ratios seem to support the superiority of
ntra-articular CRP.
Our results suggest that intra-articular CRP assay may  be useful
or diagnosing knee prosthesis infection and perhaps more broadly
eriprosthetic infection at any site. A multicentre study in a larger
ample size is being designed.
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